Details for Patent: 11,400,101
✉ Email this page to a colleague
Which drugs does patent 11,400,101 protect, and when does it expire?
Patent 11,400,101 protects RYALTRIS and is included in one NDA.
This patent has seventy-eight patent family members in thirty countries.
Summary for Patent: 11,400,101
| Title: | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| Abstract: | The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt. |
| Inventor(s): | Khairatkar-Joshi; Neelima (Thane, IN), Kulkarni; Abhay (Navi Mumbai, IN), Wale; Dinesh Pradeep (Maharashtra, IN), Bhosale; Vikram M. (Mumbai, IN), Agarwal; Piyush (Mumbai, IN), Keohane; Patrick (London, GB), Tantry; Sudeesh K. (Jamison, PA), Oh; Chad (San Francisco, CA) |
| Assignee: | GLENMARK SPECIALTY S.A. (La Chaux-de-Fonds, CH) |
| Application Number: | 17/003,584 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,400,101
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Specialty | RYALTRIS | mometasone furoate; olopatadine hydrochloride | SPRAY, METERED;NASAL | 211746-001 | Jan 13, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF SEASONAL ALLERGIC RHINITIS BY NASALY ADMINISTERING A COMBINATION OF OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,400,101
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| India | 3174/MUM/2013 | Oct 4, 2013 |
International Family Members for US Patent 11,400,101
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3043773 | ⤷ Sign Up | CA 2021 00050 | Denmark | ⤷ Sign Up |
| European Patent Office | 3043773 | ⤷ Sign Up | 301154 | Netherlands | ⤷ Sign Up |
| European Patent Office | 3043773 | ⤷ Sign Up | 122021000085 | Germany | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
